Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Umecrine Cognition AB said the final patient follow-up is complete in its randomized, placebo-controlled Phase 1b/2a PBC study of golexanolone; results are expected early November 2026.Material DetailsContext by AI AnalystThis marks an operational milestone ahead of a near-term efficacy readout in…
KDventures said its portfolio company Umecrine Cognition has reached last patient out in a randomized Phase 1b/2a study of golexanolone in PBC. Data readout is expected in early November 2026 after database lock and independent analysis.Material DetailsContext by AI AnalystThis is an operational mi…